JP2019514970A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019514970A5 JP2019514970A5 JP2018558199A JP2018558199A JP2019514970A5 JP 2019514970 A5 JP2019514970 A5 JP 2019514970A5 JP 2018558199 A JP2018558199 A JP 2018558199A JP 2018558199 A JP2018558199 A JP 2018558199A JP 2019514970 A5 JP2019514970 A5 JP 2019514970A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- antimetabolite
- individual
- bladder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021172052A JP2022009327A (ja) | 2016-05-06 | 2021-10-21 | 下部尿路上皮がんを処置する方法 |
| JP2023206570A JP2024028881A (ja) | 2016-05-06 | 2023-12-07 | 下部尿路上皮がんを処置する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662333151P | 2016-05-06 | 2016-05-06 | |
| US62/333,151 | 2016-05-06 | ||
| US201762443614P | 2017-01-06 | 2017-01-06 | |
| US62/443,614 | 2017-01-06 | ||
| PCT/US2017/031445 WO2017193098A1 (en) | 2016-05-06 | 2017-05-05 | Method of treating lower tract urothelial cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021172052A Division JP2022009327A (ja) | 2016-05-06 | 2021-10-21 | 下部尿路上皮がんを処置する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019514970A JP2019514970A (ja) | 2019-06-06 |
| JP2019514970A5 true JP2019514970A5 (enExample) | 2020-06-18 |
| JP7712055B2 JP7712055B2 (ja) | 2025-07-23 |
Family
ID=60203435
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018558199A Active JP7712055B2 (ja) | 2016-05-06 | 2017-05-05 | 下部尿路上皮がんを処置する方法 |
| JP2021172052A Withdrawn JP2022009327A (ja) | 2016-05-06 | 2021-10-21 | 下部尿路上皮がんを処置する方法 |
| JP2023206570A Pending JP2024028881A (ja) | 2016-05-06 | 2023-12-07 | 下部尿路上皮がんを処置する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021172052A Withdrawn JP2022009327A (ja) | 2016-05-06 | 2021-10-21 | 下部尿路上皮がんを処置する方法 |
| JP2023206570A Pending JP2024028881A (ja) | 2016-05-06 | 2023-12-07 | 下部尿路上皮がんを処置する方法 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20190388338A1 (enExample) |
| EP (2) | EP3452053B1 (enExample) |
| JP (3) | JP7712055B2 (enExample) |
| KR (2) | KR20220123317A (enExample) |
| CN (2) | CN109475571A (enExample) |
| AU (1) | AU2017261371B2 (enExample) |
| CA (1) | CA3023274A1 (enExample) |
| ES (1) | ES2940227T3 (enExample) |
| FI (1) | FI3452053T3 (enExample) |
| HR (1) | HRP20221544T1 (enExample) |
| HU (1) | HUE060965T2 (enExample) |
| IL (2) | IL295592A (enExample) |
| LT (1) | LT3452053T (enExample) |
| MX (2) | MX389296B (enExample) |
| NZ (3) | NZ787786A (enExample) |
| PL (1) | PL3452053T3 (enExample) |
| PT (1) | PT3452053T (enExample) |
| RS (1) | RS64032B1 (enExample) |
| RU (2) | RU2022100624A (enExample) |
| SG (2) | SG10201913416PA (enExample) |
| SI (1) | SI3452053T1 (enExample) |
| SM (1) | SMT202300047T1 (enExample) |
| WO (1) | WO2017193098A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3370768T1 (sl) | 2015-11-03 | 2022-04-29 | Janssen Biotech, Inc. | Protitelesa, ki se specifično vežejo na PD-1, in njihove uporabe |
| CA3037380A1 (en) | 2016-10-11 | 2018-04-19 | Agenus Inc. | Anti-lag-3 antibodies and methods of use thereof |
| WO2019023388A1 (en) * | 2017-07-25 | 2019-01-31 | Taris Biomedical Llc | METHODS OF TREATING TUMOR METASTASIS |
| PE20210041A1 (es) * | 2017-11-08 | 2021-01-08 | Taris Biomedical Llc | Metodos de tratamiento y terapia de mantenimiento para el cancer de vejiga con gemcitabina |
| US12398209B2 (en) | 2018-01-22 | 2025-08-26 | Janssen Biotech, Inc. | Methods of treating cancers with antagonistic anti-PD-1 antibodies |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY30915A1 (es) * | 2007-02-16 | 2008-09-02 | Smithkline Beecham Corp | Método de tratamiento de canceres |
| US8343516B2 (en) | 2009-06-26 | 2013-01-01 | Taris Biomedical, Inc. | Solid drug tablets for implantable drug delivery devices |
| US8679094B2 (en) | 2009-12-17 | 2014-03-25 | Taris Biomedical, Inc. | Implantable device with intravesical tolerability and methods of treatment |
| WO2011153009A1 (en) * | 2010-06-02 | 2011-12-08 | Abraxis Bioscience, Llc | Methods of treating bladder cancer |
| PT2600800T (pt) | 2010-08-05 | 2020-11-05 | Taris Biomedical Llc | Dispositivo de administração de drogas por stent ureteral, kit e método |
| WO2012106714A1 (en) | 2011-02-04 | 2012-08-09 | Taris Biomedical, Inc. | Implantable device for controlled release of low solubility drug |
| US20150216937A1 (en) * | 2012-03-29 | 2015-08-06 | Altor Bioscience Corporation | Methods for treating neoplasia |
| KR102383496B1 (ko) | 2012-08-31 | 2022-04-08 | 타리스 바이오메디컬 엘엘씨 | 젬시타빈을 포함하는 전립선 질환의 치료를 위한 약물 전달 시스템과 방법 |
| RU2657591C2 (ru) * | 2012-08-31 | 2018-06-14 | ТАРИС Биомедикал ЛЛК | Способ лечения рака мочевого пузыря оксалиплатином, соответствующее устройство его доставки, способ и устройство его введения |
| JP2016508842A (ja) | 2013-03-05 | 2016-03-24 | タリス バイオメディカル エルエルシー | 装置の開口部を通じて制御された薬物放出のための薬物送達装置及び方法 |
| EP2968120A1 (en) | 2013-03-15 | 2016-01-20 | TARIS Biomedical LLC | Drug delivery devices and methods for drug delivery |
| SG11201507294WA (en) | 2013-03-15 | 2015-10-29 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
| WO2015026813A1 (en) | 2013-08-19 | 2015-02-26 | Taris Biomedical Llc | Multi-unit drug delivery devices and methods |
| HRP20251264T1 (hr) * | 2014-03-06 | 2025-12-05 | Taris Biomedical Llc | Sustavi za primjenu lijeka i metode za liječenje karcinoma mokraćnog mjehura gemcitabinom |
| KR102391761B1 (ko) | 2014-06-26 | 2022-04-27 | 타리스 바이오메디컬 엘엘씨 | 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법 |
| WO2016172704A1 (en) | 2015-04-23 | 2016-10-27 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
-
2017
- 2017-05-05 ES ES17793523T patent/ES2940227T3/es active Active
- 2017-05-05 SG SG10201913416PA patent/SG10201913416PA/en unknown
- 2017-05-05 IL IL295592A patent/IL295592A/en unknown
- 2017-05-05 RU RU2022100624A patent/RU2022100624A/ru unknown
- 2017-05-05 KR KR1020227028547A patent/KR20220123317A/ko not_active Ceased
- 2017-05-05 WO PCT/US2017/031445 patent/WO2017193098A1/en not_active Ceased
- 2017-05-05 SI SI201731301T patent/SI3452053T1/sl unknown
- 2017-05-05 US US16/099,179 patent/US20190388338A1/en active Pending
- 2017-05-05 AU AU2017261371A patent/AU2017261371B2/en active Active
- 2017-05-05 MX MX2018013432A patent/MX389296B/es unknown
- 2017-05-05 SM SM20230047T patent/SMT202300047T1/it unknown
- 2017-05-05 CN CN201780040391.1A patent/CN109475571A/zh active Pending
- 2017-05-05 NZ NZ787786A patent/NZ787786A/en unknown
- 2017-05-05 HU HUE17793523A patent/HUE060965T2/hu unknown
- 2017-05-05 PL PL17793523.6T patent/PL3452053T3/pl unknown
- 2017-05-05 NZ NZ748252A patent/NZ748252A/en unknown
- 2017-05-05 SG SG11201809838VA patent/SG11201809838VA/en unknown
- 2017-05-05 CA CA3023274A patent/CA3023274A1/en active Pending
- 2017-05-05 LT LTEPPCT/US2017/031445T patent/LT3452053T/lt unknown
- 2017-05-05 CN CN202410626384.1A patent/CN118453872A/zh active Pending
- 2017-05-05 RS RS20230163A patent/RS64032B1/sr unknown
- 2017-05-05 HR HRP20221544TT patent/HRP20221544T1/hr unknown
- 2017-05-05 KR KR1020187035297A patent/KR102435709B1/ko active Active
- 2017-05-05 FI FIEP17793523.6T patent/FI3452053T3/fi active
- 2017-05-05 RU RU2018142908A patent/RU2764747C2/ru active
- 2017-05-05 EP EP17793523.6A patent/EP3452053B1/en active Active
- 2017-05-05 PT PT177935236T patent/PT3452053T/pt unknown
- 2017-05-05 NZ NZ787824A patent/NZ787824A/en unknown
- 2017-05-05 IL IL262746A patent/IL262746B/en unknown
- 2017-05-05 JP JP2018558199A patent/JP7712055B2/ja active Active
- 2017-05-05 EP EP22212024.8A patent/EP4209221A1/en active Pending
-
2018
- 2018-11-01 MX MX2021013461A patent/MX2021013461A/es unknown
-
2021
- 2021-10-21 JP JP2021172052A patent/JP2022009327A/ja not_active Withdrawn
-
2023
- 2023-12-07 JP JP2023206570A patent/JP2024028881A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lee et al. | Immune checkpoint inhibitors in 10 years: contribution of basic research and clinical application in cancer immunotherapy | |
| JP2019514970A5 (enExample) | ||
| US10076528B2 (en) | System and method for diagnosis and treatment | |
| Antonia et al. | Immuno-oncology combinations: a review of clinical experience and future prospects | |
| Pramyothin et al. | Vitamin D in adipose tissue and serum 25‐hydroxyvitamin D after roux‐en‐Y gastric bypass | |
| JP2019522657A5 (enExample) | ||
| RU2022100624A (ru) | Способ лечения рака уротелия нижних путей | |
| Shaikh et al. | Engineering stent based delivery system for esophageal cancer using docetaxel | |
| Denlinger et al. | A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers | |
| Hoag et al. | Association of cetuximab with adverse pulmonary events in cancer patients: a comprehensive review | |
| Coloma et al. | High incidence of cetuximab-related infusion reactions in head and neck patients | |
| CN101612141B (zh) | 丁丙诺啡贴剂 | |
| CN119923256A (zh) | 包含大麻素的连续递送系统及其医药用途 | |
| Komarnitsky et al. | P1. 04-006 rovalpituzumab tesirine vs topotecan in patients with advanced small cell lung cancer following 1st line chemotherapy | |
| Knight et al. | Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine | |
| Islam et al. | Marital Status and Survival in Patients with Multiple Myeloma: The Role of Marriage in the Management of Multiple Myeloma | |
| El Akkawi et al. | Systematic Review with Meta-analysis: Denosumab in Gluco-corticoids Induced Osteoporosis | |
| Seminario-Vidal et al. | 283 Toxic epidermal necrolysis in the setting of acute graft-versus-host disease successfully treated with tumor necrosis factor alpha inhibitors | |
| Vidal et al. | Legionella in a patient with rheumatoid arthritis receiving abatacept | |
| HK40005970A (en) | Method of treating lower tract urothelial cancer | |
| HK40044298A (en) | Microbiome related immunotherapies | |
| Wardley et al. | Zometa®(zoledronic acid) in patients with skeletal metastases secondary to breast cancer—a study of home versus hospital administration | |
| JPWO2021161032A5 (enExample) |